| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-13 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-13 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-12 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-12 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-11 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-11 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-11 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
8e-11 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-11 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-10 |